Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-22 19:49:49 UTC |
---|
Update Date | 2019-07-23 07:15:49 UTC |
---|
HMDB ID | HMDB0061130 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 8-Hydroxynevirapine glucuronide |
---|
Description | 8-Hydroxynevirapine glucuronide is a metabolite of nevirapine. Nevirapine, also marketed under the trade name Viramune, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. (Wikipedia) |
---|
Structure | CC1=CC=NC2=C1NC(=O)C1=C(N=CC(O[C@H]3O[C@H]([C@H](O)[C@@H](O)[C@@H]3O)C(O)=O)=C1)N2C1CC1 InChI=1S/C21H22N4O8/c1-8-4-5-22-18-12(8)24-19(29)11-6-10(7-23-17(11)25(18)9-2-3-9)32-21-15(28)13(26)14(27)16(33-21)20(30)31/h4-7,9,13-16,21,26-28H,2-3H2,1H3,(H,24,29)(H,30,31)/t13-,14-,15+,16-,21+/m1/s1 |
---|
Synonyms | Value | Source |
---|
5-Hydroxy, 6-methoxy duloxetine sulfuric acid | HMDB | 5-Hydroxy, 6-methoxy duloxetine sulphate | HMDB | 5-Hydroxy, 6-methoxy duloxetine sulphuric acid | HMDB |
|
---|
Chemical Formula | C21H22N4O8 |
---|
Average Molecular Weight | 458.4214 |
---|
Monoisotopic Molecular Weight | 458.1437637 |
---|
IUPAC Name | (2R,3R,4R,5S,6R)-6-({2-cyclopropyl-7-methyl-10-oxo-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-13-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
Traditional Name | (2R,3R,4R,5S,6R)-6-({2-cyclopropyl-7-methyl-10-oxo-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-13-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CC=NC2=C1NC(=O)C1=C(N=CC(O[C@H]3O[C@H]([C@H](O)[C@@H](O)[C@@H]3O)C(O)=O)=C1)N2C1CC1 |
---|
InChI Identifier | InChI=1S/C21H22N4O8/c1-8-4-5-22-18-12(8)24-19(29)11-6-10(7-23-17(11)25(18)9-2-3-9)32-21-15(28)13(26)14(27)16(33-21)20(30)31/h4-7,9,13-16,21,26-28H,2-3H2,1H3,(H,24,29)(H,30,31)/t13-,14-,15+,16-,21+/m1/s1 |
---|
InChI Key | IVZWGLRSSHUFTI-WCYOCWRHSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as o-glucuronides. These are glucuronides in which the aglycone is linked to the carbohydrate unit through an O-glycosidic bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | O-glucuronides |
---|
Alternative Parents | |
---|
Substituents | - 1-o-glucuronide
- O-glucuronide
- Hexose monosaccharide
- Alkyldiarylamine
- Glycosyl compound
- O-glycosyl compound
- Pyrido-para-diazepine
- Para-diazepine
- Beta-hydroxy acid
- Methylpyridine
- Hydroxy acid
- Monosaccharide
- Oxane
- Pyran
- Pyridine
- Imidolactam
- Vinylogous amide
- Heteroaromatic compound
- Secondary carboxylic acid amide
- Secondary alcohol
- Lactam
- Carboxamide group
- Polyol
- Azacycle
- Oxacycle
- Acetal
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Carboxylic acid derivative
- Carboxylic acid
- Carbonyl group
- Organic oxide
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Organonitrogen compound
- Alcohol
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
8-Hydroxynevirapine glucuronide,1TMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4006.8 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TMS,isomer #2 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4011.5 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TMS,isomer #3 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 4008.3 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TMS,isomer #4 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4030.0 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TMS,isomer #5 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 3792.3 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 3940.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #10 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 3694.8 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #2 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 3918.3 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #3 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3920.5 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #4 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 3728.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #5 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 3922.0 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #6 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3921.3 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #7 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 3728.3 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #8 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3923.6 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TMS,isomer #9 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3725.5 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 3905.1 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #10 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3676.0 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #2 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3896.8 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #3 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 3700.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #4 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3892.6 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #5 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 3692.0 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #6 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3695.0 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #7 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3894.7 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #8 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 3665.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TMS,isomer #9 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3689.7 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,4TMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3912.3 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,4TMS,isomer #2 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 3689.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,4TMS,isomer #3 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3692.0 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,4TMS,isomer #4 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3702.5 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,4TMS,isomer #5 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3674.6 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,5TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3728.9 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,5TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 3733.0 | Standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,5TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)=CN=C1N2C1CC1 | 4771.0 | Standard polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TBDMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4220.6 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TBDMS,isomer #2 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4221.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TBDMS,isomer #3 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4220.3 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TBDMS,isomer #4 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4247.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,1TBDMS,isomer #5 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4087.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4285.6 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #10 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4130.7 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #2 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4242.1 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #3 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4243.7 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #4 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4131.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #5 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4256.8 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #6 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4246.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #7 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4121.4 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #8 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4266.9 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,2TBDMS,isomer #9 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4130.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #1 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4359.1 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #10 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4186.1 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #2 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4357.9 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #3 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O)=CN=C1N2C1CC1 | 4200.8 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #4 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4338.7 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #5 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4173.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #6 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4182.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #7 | CC1=CC=NC2=C1NC(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4355.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #8 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)=CN=C1N2C1CC1 | 4165.2 | Semi standard non polar | 33892256 | 8-Hydroxynevirapine glucuronide,3TBDMS,isomer #9 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC(O[C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[Si](C)(C)C(C)(C)C)=CN=C1N2C1CC1 | 4173.8 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 8-Hydroxynevirapine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-054o-9118400000-a7a05c6f368a05bcc1a5 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 8-Hydroxynevirapine glucuronide GC-MS (3 TMS) - 70eV, Positive | splash10-0a4i-4701139000-644ea49eb1d875f7ac7c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 8-Hydroxynevirapine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 10V, Positive-QTOF | splash10-05o3-0090600000-4b470bd74c1897d1be88 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 20V, Positive-QTOF | splash10-0159-0090000000-1bbb0d8feb9db6b86895 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 40V, Positive-QTOF | splash10-00l6-4390000000-dccc34373a73b424ac72 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 10V, Negative-QTOF | splash10-0bu0-2270900000-082906c44d4658ff7443 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 20V, Negative-QTOF | splash10-001i-1291300000-411202794ed528c9222e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 40V, Negative-QTOF | splash10-053r-2390000000-27c8ea77e71c8756aa5b | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 10V, Positive-QTOF | splash10-0a4l-0000900000-2b3cd07f30dc9e4ccd35 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 20V, Positive-QTOF | splash10-0l0x-0018900000-f0895d06e7c830bde767 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 40V, Positive-QTOF | splash10-0006-0193100000-c4bf0ec73cc4fd8eef9e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 10V, Negative-QTOF | splash10-0a4i-0120900000-5a5943a8448c295c1b66 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 20V, Negative-QTOF | splash10-0540-4292500000-8f036fbf67ac16bbd6ee | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 8-Hydroxynevirapine glucuronide 40V, Negative-QTOF | splash10-000i-1091000000-4be90d27dfb43b58b459 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 30778632 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 131770041 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 190789 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | Not Available |
---|